Le centre hospitalier universitaire Amiens-Picardie est un centre hospitalier universitaire d'une capacité totale de 1 701 lits et places en 2020. Situé à Amiens en région Hauts-de-France, le CHU Amiens-Picardie est composé de trois sites distincts : le site sud ; le site nord ; le centre Saint-Victor.

During the past decade, Chu Amiens conducted 590 clinical trials. In the 10-year time frame, 590 clinical trials started and 42 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 239 clinical trials started and 24 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chu Amiens" #1 sponsor was "Centre Hospitalier Universitaire, Amiens" with 342 trials, followed by "University Hospital, Lille" with 27 trials sponsored, "Groupe Francophone des Myelodysplasies" with 19 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 16 trials sponsored and "Nantes University Hospital" with 16 trials sponsored. Other sponsors include 447 different institutions and companies that sponsored additional 176 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chu Amiens" #1 collaborator was "Ministry of Health, France" with 27 trials as a collaborator, "National Cancer Institute, France" with 11 trials as a collaborator, "University Hospital, Lille" with 11 trials as a collaborator, "University Hospital, Caen" with 9 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 8 trials as a collaborator. Other collaborators include 422 different institutions and companies that were collaborators in the rest 305 trials.

According to Clinical.Site data, the most researched conditions in "Chu Amiens" are "Myelodysplastic Syndromes" (20 trials), "Ulcerative Colitis" (20 trials), "Crohn's Disease" (19 trials), "Multiple Myeloma" (15 trials) and "Crohn Disease" (13 trials). Many other conditions were trialed in "Chu Amiens" in a lesser frequency.

Most popular intervention types in "Chu Amiens" are "Drug" (328 trials), "Other" (247 trials), "Procedure" (89 trials), "Device" (82 trials) and "Biological" (65 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (73 trials), "blood sample" (14 trials), "Rituximab" (8 trials), "Bevacizumab" (7 trials) and "Cyclophosphamide" (7 trials). Other intervention names were less common.

The vast majority of trials in "Chu Amiens" are 818 trials for "All" genders, 45 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 343 active trials in "Chu Amiens". 12 are not yet recruiting, 256 are recruiting, 74 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 346 completed trials in Chu Amiens, 1 suspended trials, and 55 terminated clinical trials to date.

Out of the total trials that were conducted in Chu Amiens, 17 "Phase 1" clinical trials were conducted, 146 "Phase 2" clinical trials and 189 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 257 trials that are defined as “Not Applicable".

Chu Amiens has several departments that took part in Clinical trials: "CHU Amiens Hopital Sud; Neurologie" - 5 trials, "CHU Amiens Picardie-Site Sud - RDC Service Hépato gastro" - 4 trials, "Hopital Sud ; Nephrologie Hemodialyse" - 3 trials, "Service de Pathologies infectieuses et tropicales, Hôpital Nord, CHU d'Amiens" - 2 trials, "CHU Amiens-Picardie Service De Neurologie Pediatrique" - 2 trials